What are the causes of myopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Myopathy

Myopathies are broadly categorized into inflammatory and noninflammatory causes, with the differential diagnosis requiring systematic evaluation to distinguish between immune-mediated, genetic, metabolic, endocrine, drug-induced, and infectious etiologies 1.

Major Categories of Myopathy

Inflammatory Myopathies (Idiopathic Inflammatory Myopathies)

The idiopathic inflammatory myopathies represent a distinct group of autoimmune muscle diseases 1:

  • Polymyositis (PM): Characterized by CD8+ cytotoxic T cells invading nonnecrotic muscle fibers, presenting with symmetric proximal muscle weakness 1

  • Dermatomyositis (DM): Features characteristic skin manifestations (Gottron papules, heliotrope rash, shawl sign) along with proximal muscle weakness, elevated muscle enzymes, and potential extramuscular involvement including interstitial lung disease and cardiac manifestations 1

  • Immune-Mediated Necrotizing Myopathy (IMNM): A severe myopathy with minimal inflammatory infiltrate on biopsy, triggered by viral infections, medications (particularly statins), and malignant neoplasms 1. Statin-induced necrotizing myopathy is associated with antibodies against HMGCR protein 1

  • Sporadic Inclusion Body Myositis (sIBM): Has degenerative features with muscle fiber vacuolization and abnormal accumulation of amyloid-β and phosphorylated tau proteins 1

  • Juvenile Dermatomyositis (JDM): Affects children under 18 years with proximal muscle weakness, calcinosis cutis, cutaneous vasculitis, and gastrointestinal vasculopathy 1

Noninflammatory Myopathies

The differential diagnosis of noninflammatory myopathies is extensive and must be systematically excluded when evaluating proximal muscle weakness with elevated muscle enzymes 1:

Genetic/Hereditary Causes

  • Muscular dystrophies: Late-onset muscular dystrophy, limb-girdle dystrophy (dysferlinopathies) with adult onset, myotonic dystrophy type 2 1
  • Mitochondrial myopathies: Show classic "ragged red fibers" on Gomori trichrome stain with subsarcolemmal and interfibrillar mitochondrial accumulation 1
  • Adult-onset nemaline myopathy: Associated with monoclonal gammopathy 1

Drug-Induced Myopathy

  • Statins are the most clinically significant medication trigger, capable of causing both toxic myopathy and immune-mediated necrotizing myopathy 1
  • Other medications can trigger IMNM 1

Endocrine Myopathies

  • Thyroid disorders (both hypothyroidism and hyperthyroidism) 1
  • Hyperparathyroidism 1

Metabolic Myopathies

  • Various metabolic derangements affecting muscle function 1

Infectious Myopathies

  • Viral infections can trigger IMNM 1
  • Direct infectious myositis from various pathogens 1

Malignancy-Associated

  • Cancer can trigger immune-mediated necrotizing myopathy 1
  • Paraneoplastic myopathy syndromes

Critical Diagnostic Distinctions

Muscle biopsy remains the gold standard for differentiating inflammatory from noninflammatory myopathy and for subclassification 1. Key histopathologic features distinguish these entities:

  • Muscular dystrophy: Reduction or absence of dystrophin with degenerating/regenerating fibers and replacement with fat or connective tissue 1
  • Mitochondrial myopathy: Ragged red fibers with reduction or absence of cytochrome c oxidase 1
  • Inflammatory myopathy: Endomysial mononuclear inflammatory infiltrate 1

Common Pitfall

A critical error is assuming all proximal weakness with elevated CK is inflammatory myositis. Muscular dystrophy and mitochondrial myopathies must be included in the differential diagnosis, as they can present identically with proximal muscle weakness and elevated muscle enzymes 1. Genetic testing for dystrophin gene and specialized staining techniques are essential when clinical suspicion exists.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.